Defensin beta 108C (DEFB108C)

Defensin beta 108C (DEFB108C) is annotated as a member of the beta-defensin gene family, which encodes small, cysteine-rich, cationic peptides implicated in the innate immune response by providing antimicrobial activity against bacteria, fungi, and viruses[1][4][5]. Beta-defensins are structurally characterized by three intramolecular disulfide bonds formed by six conserved cysteines, conferring stability and functionality to active peptides[1][2][5]. However, DEFB108C is commonly designated as a "putative" defensin, with aliases indicating it may represent a pseudogene or unconfirmed locus lacking direct evidence of functional protein expression or physiological role, especially in humans. There are no known drugs, specific disease links, or established mechanisms associated with DEFB108C specifically. The broader family is involved in host defense, but 108C requires further functional evidence for clinical or pharmacological relevance[1][4]. Key points: DEFB108C is not a verified protein target; it is annotated but possibly nonfunctional in humans. No evidence supports use as a therapeutic target, biomarker, or drug-interacting protein. Beta-defensin family is important in immunity, but the function/importance of 108C is uncharacterized. Potential errors include over-attribution of function or inclusion as a druggable target without supporting data.

Other names

Putative beta-defensin 108ADEFB108ADEFB108P1DEFB108P2Defensin, beta 108ADefensin, beta 108CPutative beta-defensin 108B pseudogene 1Putative beta-defensin 108B pseudogene 2

None established